These findings have been summarized in a relevant meta-analysis that found that per 1 standard deviation increase in IL-6 levels, there was a significantly increased hazard for nonfatal MI and CAD-related death (HR:1.25 (1.19–1.32)). The gene discussed is IL6; the disease is coronary artery disorder.